Afatinib Recruiting Phase 1 Trials for Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01783587Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer